Matthias Bozza is a pragmatic and results-oriented molecular biologist specializing in gene and cell therapy, with a focus on oncology. They have served as a Post Doctoral Researcher at DKFZ German Cancer Research Center, where they developed a non-viral DNA vector platform and advanced novel CMC processes for cellular therapies. Currently, Matthias is the Director and Head of Strategy and R&D at CPTx, and has held leadership positions at Vector BioPharma and Ridgeline Discovery, focusing on innovation, pre-clinical development, and corporate strategy. Additionally, they contribute as a Review Editor on the Editorial Board of Cancer Immunity and Immunotherapy. Matthias obtained their PhD in Molecular Biology from DKFZ German Cancer Research Center.
This person is not in the org chart
This person is not in any teams
This person is not in any offices